Giovanni Piotti

Parma, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Long-term efficacy and safety of pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease: results from up to 5 years of the BRIGHT F51 phase III, open-label extension study.

Long-term efficacy and safety of pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease: results from up to 5 years of the BRIGHT F51 phase III, open-label extension study.

Journal: Orphanet journal of rare diseases

Published: November 12, 2025

Impact of Proteinuria on Renal Outcomes in the BALANCE Trial.

Impact of Proteinuria on Renal Outcomes in the BALANCE Trial.

Journal: Kidney international reports

Published: September 18, 2025

Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe.

Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: November 12, 2021

Therapeutic Drug Monitoring Strategies for Envarsus in De Novo Kidney Transplant Patients Using Population Modelling and Simulations.

Therapeutic Drug Monitoring Strategies for Envarsus in De Novo Kidney Transplant Patients Using Population Modelling and Simulations.

Journal: Advances in therapy

Published: July 24, 2021

Frailty and Sarcopenia in Older Patients Receiving Kidney Transplantation.

Frailty and Sarcopenia in Older Patients Receiving Kidney Transplantation.

Journal: Frontiers in nutrition

Published: July 16, 2019

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.

Journal: Advances in therapy

Published: October 01, 2018

Dietary protein and nutritional supplements in conventional hemodialysis.

Dietary protein and nutritional supplements in conventional hemodialysis.

Journal: Seminars in dialysis

Published: June 18, 2018

Metabolic risk profile in kidney transplant candidates and recipients.

Metabolic risk profile in kidney transplant candidates and recipients.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: April 06, 2018

Contrast medium induced acute kidney injury: a narrative review.

Contrast medium induced acute kidney injury: a narrative review.

Journal: Journal of nephrology

Published: April 06, 2018

Rapid Biolayer Interferometry Measurements of Urinary CXCL9 to Detect Cellular Infiltrates Noninvasively After Kidney Transplantation.

Rapid Biolayer Interferometry Measurements of Urinary CXCL9 to Detect Cellular Infiltrates Noninvasively After Kidney Transplantation.

Journal: Kidney international reports

Published: May 13, 2017

Once-daily prolonged-release tacrolimus formulations for kidney transplantation: what the nephrologist needs to know.

Once-daily prolonged-release tacrolimus formulations for kidney transplantation: what the nephrologist needs to know.

Journal: Journal of nephrology

Published: April 12, 2016

Protein-energy wasting and nutritional supplementation in chronic hemodialysis

Protein-energy wasting and nutritional supplementation in chronic hemodialysis

Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

Published: October 20, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026